Olivia Hernández-González
Olivia Hernández-González has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Hidalgo-Bravo
Departamento de Medicina Genómica, Instituto Nacional de Rehabilitación (INR), Mexico City 14389, Mexico
1 shared publication - Alexandra Luna-Angulo
Neuromuscular Diseases Laboratory, Clinical Neurosciences Division, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico
1 shared publication - Beatriz del Carmen Couder-García
SECIHTI-Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Subsede Sureste, Parque Científico Tecnológico de Yucatán, Tablaje Catastral 31264, Mérida 97302, México.
1 shared publication Brandon Eduardo Galicia-Canales
Cellular Therapy and Regenerative Medicine Tissue Engineering Unit, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
1 shared publication- Carlos Landa-Solís
Tissue Engineering, Cell Therapy and Regenerative Medicine Unit, National Institute of Rehabilitation “Luis Guillermo Ibarra Ibarra”, Mexico City 14389, Mexico
1 shared publication - Dalia Lizbeth Monroy-Quiroz
Cellular Therapy and Regenerative Medicine Tissue Engineering Unit, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
1 shared publication
Latest Publications
- Open Access
- 30 July 2025
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 71 (7) , 108-113
Molecular evaluation of quercetin effects in a murine model of giant cell tumor of bone: an in vivo pilot study
Quercetin, a flavonoid derived from plant sources, has been extensively studied for its numerous biological properties, particularly its potential antitumor action against various malignant neoplasms. In our experience with a giant cell tumor of bone cell line (TIB-223), we demonstrated that quercetin has the ability to induce apoptosis via caspase-3. Therefore, this study aimed to evaluate molecular markers for apoptosis, necrosis, and cell proliferation in a murine model of giant cell tumor of bone, to determine whether the behavior reported for quercetin in 2D remains consistent in a 3D in vivo tumor model. Tumor constructs based on TIB-223 cells were implanted into athymic mice, and two weeks post-implantation, the mice were orally administered quercetin at a concentration of 100 mg/kg body weight once a day for two weeks. The control group received only 200 µL of the vehicle. Our results demonstrate the activation of two cell death pathways in the implanted tumors: apoptosis, via Caspase-8 to Caspase-3 activation, and necroptosis, via RIPK1. No significant effect on cell proliferation was observed, as PCNA expression remained unchanged. Our results suggest that quercetin may induce specific mechanisms of cell death without significantly altering cell proliferation in the tumor model induced in mice.
- 30 July 2025
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 71 (7) , 108-113
Open AccessMolecular evaluation of quercetin effects in a murine model of giant cell tumor of bone: an in vivo pilot study
Quercetin, a flavonoid derived from plant sources, has been extensively studied for its numerous biological properties, particularly its potential antitumor action against various malignant neoplasms. In our experience with a giant cell tumor of bone cell line (TIB-223), we demonstrated that quercetin has the ability to induce apoptosis via caspase-3. Therefore, this study aimed to evaluate molecular markers for apoptosis, necrosis, and cell proliferation in a murine model of giant cell tumor of bone, to determine whether the behavior reported for quercetin in 2D remains consistent in a 3D in vivo tumor model. Tumor constructs based on TIB-223 cells were implanted into athymic mice, and two weeks post-implantation, the mice were orally administered quercetin at a concentration of 100 mg/kg body weight once a day for two weeks. The control group received only 200 µL of the vehicle. Our results demonstrate the activation of two cell death pathways in the implanted tumors: apoptosis, via Caspase-8 to Caspase-3 activation, and necroptosis, via RIPK1. No significant effect on cell proliferation was observed, as PCNA expression remained unchanged. Our results suggest that quercetin may induce specific mechanisms of cell death without significantly altering cell proliferation in the tumor model induced in mice.